Literature DB >> 9040660

Clinical and prognostic features in unilateral femoral neuropathies.

T Kuntzer1, G van Melle, F Regli.   

Abstract

We have examined the clinical features of patients with femoral neuropathy and the factors that influence the prognosis. Of 80 consecutive patients referred for neurophysiological evaluations of proximal lower limb weakness, 32 fulfilled strict inclusion criteria and had adequate information, including estimates of axon loss (AxL) by stimulation of the bilateral femoral nerve. In 31, the Kaplan-Meier method was used to describe the time course of the outcome, while logistic regression was employed to determine the contributing factors. Excellent, satisfactory, and poor outcomes were seen in 10 (31%), 11 (34%), and 10 (31%) patients, respectively. Logistic regression analysis of seven factors demonstrated that the estimate of AxL was the only significant variable. The best prognostic factor was an estimate of AxL < or = 50%, with all patients fulfilling this criterion showing improvement with 1 year; fewer than half the patients with AxL > 50% should be expected to improve. This study clearly shows that, irrespective of the cause of femoral neuropathy, functional improvement is seen in 2 out of 3 patients within 2 years and that the estimate of AxL is the only factor influencing prognosis.

Entities:  

Mesh:

Year:  1997        PMID: 9040660     DOI: 10.1002/(sici)1097-4598(199702)20:2<205::aid-mus11>3.0.co;2-1

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Femoral neuropathy induced by a low-grade myofibroblastic sarcoma of the groin.

Authors:  Yasutaka Tajima; Kazumasa Sudoh; Akihisa Matsumoto; Seiji Kikuchi; Hidenao Sasaki
Journal:  J Neurol       Date:  2005-06-27       Impact factor: 4.849

2.  Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescent.

Authors:  Ludmyla Kachko; Shiri Ben Ami; Alon Liberman; Einat Birk; Sefi Kronenberg
Journal:  Pain Res Manag       Date:  2011 Nov-Dec       Impact factor: 3.037

3.  Femoral nerve and lumbar plexus injury after minimally invasive lateral retroperitoneal transpsoas approach: electrodiagnostic prognostic indicators and a roadmap to recovery.

Authors:  Naomi A Abel; Jacob Januszewski; Andrew C Vivas; Juan S Uribe
Journal:  Neurosurg Rev       Date:  2017-05-30       Impact factor: 3.042

4.  Diagnosis and management of "an apparent mechanical" femoral mononeuropathy: a case study.

Authors:  Ariane Desmarais; Martin Descarreaux
Journal:  J Can Chiropr Assoc       Date:  2007-12

5.  NERVE ENTRAPMENT IN THE HIP REGION: CURRENT CONCEPTS REVIEW.

Authors:  RobRoy Martin; Hal David Martin; Benjamin R Kivlan
Journal:  Int J Sports Phys Ther       Date:  2017-12

6.  Clonidine for an unusual isolated femoral nerve stretch injury.

Authors:  Prakash K Dubey
Journal:  Indian J Anaesth       Date:  2011-05

Review 7.  Iatrogenic femoral nerve injuries: Analysis of medico-legal issues through a scoping review approach.

Authors:  Filippo Gibelli; Giovanna Ricci; Ascanio Sirignano; Paolo Bailo; Domenico De Leo
Journal:  Ann Med Surg (Lond)       Date:  2021-11-10

8.  Outer electrospun polycaprolactone shell induces massive foreign body reaction and impairs axonal regeneration through 3D multichannel chitosan nerve guides.

Authors:  Sven Duda; Lutz Dreyer; Peter Behrens; Soenke Wienecke; Tanmay Chakradeo; Birgit Glasmacher; Kirsten Haastert-Talini
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

9.  Postpartum femoral neuropathy: managing the next pregnancy.

Authors:  Cathy Rowland; Daniel Kane; Maeve Eogan
Journal:  BMJ Case Rep       Date:  2019-12-29

10.  Iliopsoas hematoma presenting with sudden knee extensor weakness: A case report.

Authors:  Jae Hoon Kim; Seung Don Yoo; Dong Hwan Kim; Young Rok Han; Seung Ah Lee
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.